Monocytes with Oncogenic Mutation JAK2 V617F as a Tool for Studies of the Pathogenic Mechanisms of Myelofibrosis-Reference-Cited by-同舟云学术

Monocytes with Oncogenic Mutation JAK2 V617F as a Tool for Studies of the Pathogenic Mechanisms of Myelofibrosis

Published:2018-03 Issue:4 Volume:164 Page:569-575
ISSN:0007-4888
Container-title:Bulletin of Experimental Biology and Medicine
language:en
Short-container-title:Bull Exp Biol Med

Author:

Silyutina A. A.,Gin I. I.,Prikhod’ko S. S.,Zhuk S. V.,Butylin P. A.,Zaritskii A. Yu.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/article/10.1007/s10517-018-4033-x/fulltext.html

Reference25 articles.

1. Silyutina AA, Gin II, Matyukhina NM, Balayan EN, Butylin PA. Myelofibrosis Models: Literature Review and Own Data. Klin. Oncogematol. 2017;10(1):75-84. Russian.

2. Abdul Hameed MD, Tawa GJ, Kumar K, Ippolito DL, Lewis JA, Stallings JD, Wallqvist A. Systems level analysis and identification of pathways and networks associated with liver fibrosis. PLoS One. 2014;9(11):e112193. doi: https://doi.org/10.1371/journal.pone.0112193 .

3. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009;27:669-692.

4. Cabrera S, Gaxiola M, Arreola JL, Ramírez R, Jara P, D’Armiento J, Richards T, Selman M, Pardo A. Overexpression of MMP9 inmacrophages attenuates pulmonary fibrosis induced by bleomycin. Int. J. Biochem. Cell Biol. 2007;39(12):2324-2338.

5. Endo H, Niioka M, Sugioka Y, Itoh J, Kameyama K, Okazaki I, Ala-Aho R, Kähäri VM, Watanabe T. Matrix metalloproteinase-13 promotesrecovery from experimental liver cirrhosis in rats. Pathobiology. 2011;78(5):239-252.